Report overview
Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genome are modified), in order to make them suitable for pharmaceutical, industrial or agricultural applications. The genetically modified animals have improved growth rates, synthesized therapeutic proteins, and are resistant to various diseases. Increasing R&D by the major market players, rising regulatory approvals, and the rising focus toward cloning and transgenic animals are contributing to the market growth. However, high cost of research and development, and the ethical issues associated with animal biotechnology products may adversely affect the market growth.
This report aims to provide a comprehensive presentation of the global market for Animal Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Biotechnology. This report contains market size and forecasts of Animal Biotechnology in global, including the following market information:
Global Animal Biotechnology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Animal Biotechnology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diagnostic Tests Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Animal Biotechnology include Bayer AG, Merck &, Inc., Pfizer, Inc., Sanofi, Biogenesis Bago, Santa Cruz Biotechnology, Inc., Boehringer Inghlem, Virbac Inc. and Zoetis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Animal Biotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Animal Biotechnology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Animal Biotechnology Market Segment Percentages, by Type, 2022 (%)
Diagnostic Tests
Drugs
Reporductive & Genetic Produtcs
Vaccines
Global Animal Biotechnology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Animal Biotechnology Market Segment Percentages, by Application, 2022 (%)
Preventive Care for Animals
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Others
Global Animal Biotechnology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Animal Biotechnology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Animal Biotechnology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Animal Biotechnology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Merck &, Inc.
Pfizer, Inc.
Sanofi
Biogenesis Bago
Santa Cruz Biotechnology, Inc.
Boehringer Inghlem
Virbac Inc.
Zoetis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Animal Biotechnology, market overview.
Chapter 2: Global Animal Biotechnology market size in revenue.
Chapter 3: Detailed analysis of Animal Biotechnology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal Biotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
